Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) ...
Regeneron Is Playing Defense With Capital Allocation
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
StockStory.org on MSN4d
Regeneron’s (NASDAQ:REGN) Q4 Sales Top Estimates, Stock Soars
Biotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results , with sales up 10.3% year on year to $3.79 billion. Its ...
REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
February 4, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...
Nasdaq4d
Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend
Regeneron Pharmaceuticals ... Roche’s Vabysmo sales skyrocketed 68% to CHF 3.9 billion in 2024 on strong demand in all regions. Nonetheless, the uptake of Eylea HD is encouraging as Eylea ...
MarketWatch26d
Regeneron Working with Truveta's Network to Extend Database
The center will have exclusive rights to perform all research-related sequencing on samples collected under the collaboration, Regeneron said. Both Regeneron and Truveta will use the data to ...
FiercePharma4d
Regeneron's Libtayo reaches blockbuster status and has potential for more growth: execs
As for revenue, Regeneron reported it at $3.79 billion for the fourth quarter, which was up 10% year over year. The company's full-year haul came in at $14.2 billion, which was an increase of 8%.
Business Insider26d
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
The Regeneron Genetics Center ® has sequenced nearly three million people to date, all with deidentified linked healthcare records. A newly announced strategic collaboration with Truveta ...
Yahoo Finance26d
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database
Regeneron pledged $119.5m while Illumina is ... of the party’s pledge to fix the National Health Service (NHS). The All of Us Research Program (AOR) from the National Institutes of Health ...
Nasdaq3d
Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
Regeneron's price zoomed well higher than the ... Although that's a bit atypical, all in all it was a solid earnings report for the company. Its portfolio isn't large, but it is a good mix of ...
Seeking Alpha4d
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2024 Earnings Call Transcript
Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call. My name is Tawanda, and I will be your operator for today's call. At this time, all participants are ...